Brief: Qualigen Therapeutics, Inc. Reports Financial Results And Corporate Update For Quarter Ending March 31, 2023
16/05/2023 13:46
Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS INC QUARTERLY LOSS PER SHARE $0.78
* QUALIGEN THERAPEUTICS, INC. REPORTS FINANCIAL RESULTS AND
CORPORATE UPDATE FOR QUARTER ENDING MARCH 31, 2023
* QUALIGEN THERAPEUTICS INC - AS OF MARCH 31, 2023, COMPANY
HAD
APPROXIMATELY $4.4 MILLION IN CASH
Source text for Eikon: ID:nGNXb46rsd
Further company coverage: QLGN.O
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise